MEDINET Co., Ltd. (2370.T)
JPY 37.0
(0.0%)
JPY 37.0
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.42 Billion JPY | -6.97% |
| 2022 | -1.33 Billion JPY | -23.36% |
| 2021 | -1.08 Billion JPY | -16.69% |
| 2020 | -926.12 Million JPY | 8.15% |
| 2019 | -1 Billion JPY | 62.67% |
| 2018 | -2.7 Billion JPY | -49.94% |
| 2017 | -1.8 Billion JPY | -7.16% |
| 2016 | -1.68 Billion JPY | 3.49% |
| 2015 | -1.74 Billion JPY | -23.8% |
| 2014 | -1.4 Billion JPY | -60.28% |
| 2013 | -877.85 Million JPY | -23.44% |
| 2012 | -711.13 Million JPY | -134.24% |
| 2011 | -303.59 Million JPY | -190.89% |
| 2010 | 334.01 Million JPY | 13.7% |
| 2009 | 293.76 Million JPY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | -336.14 Million JPY | 7.47% |
| 2024 Q2 | -363.29 Million JPY | -24.27% |
| 2024 Q1 | -292.35 Million JPY | 22.98% |
| 2023 Q4 | -379.58 Million JPY | -1.35% |
| 2023 FY | -1.42 Billion JPY | -6.97% |
| 2023 Q2 | -346.32 Million JPY | -6.4% |
| 2023 Q3 | -374.54 Million JPY | -8.15% |
| 2023 Q1 | -325.49 Million JPY | 5.57% |
| 2022 FY | -1.33 Billion JPY | -23.36% |
| 2022 Q4 | -344.69 Million JPY | -11.15% |
| 2022 Q2 | -338.56 Million JPY | 0.34% |
| 2022 Q1 | -339.73 Million JPY | -17.71% |
| 2022 Q3 | -310.11 Million JPY | 8.4% |
| 2021 Q3 | -246.34 Million JPY | -2.87% |
| 2021 Q1 | -306.21 Million JPY | -8.1% |
| 2021 Q2 | -239.47 Million JPY | 21.79% |
| 2021 Q4 | -288.61 Million JPY | -17.16% |
| 2021 FY | -1.08 Billion JPY | -16.69% |
| 2020 FY | -926.12 Million JPY | 8.15% |
| 2020 Q4 | -283.26 Million JPY | -4.93% |
| 2020 Q1 | -172.33 Million JPY | -12.89% |
| 2020 Q2 | -200.56 Million JPY | -16.38% |
| 2020 Q3 | -269.95 Million JPY | -34.6% |
| 2019 Q1 | -301.11 Million JPY | 15.91% |
| 2019 Q3 | -289.63 Million JPY | -9.35% |
| 2019 Q4 | -152.65 Million JPY | 47.29% |
| 2019 FY | -1 Billion JPY | 62.67% |
| 2019 Q2 | -264.86 Million JPY | 12.04% |
| 2018 Q2 | -390.7 Million JPY | 74.35% |
| 2018 Q3 | -429.07 Million JPY | -9.82% |
| 2018 FY | -2.7 Billion JPY | -49.94% |
| 2018 Q1 | -1.52 Billion JPY | -340.39% |
| 2018 Q4 | -358.09 Million JPY | 16.54% |
| 2017 Q1 | -414.72 Million JPY | 23.95% |
| 2017 FY | -1.8 Billion JPY | -7.16% |
| 2017 Q2 | -622 Million JPY | -49.98% |
| 2017 Q4 | -345.9 Million JPY | 17.42% |
| 2017 Q3 | -418.89 Million JPY | 32.65% |
| 2016 Q4 | -545.36 Million JPY | -37.74% |
| 2016 Q1 | -374.79 Million JPY | 31.73% |
| 2016 Q2 | -365 Million JPY | 2.61% |
| 2016 Q3 | -395.93 Million JPY | -8.47% |
| 2016 FY | -1.68 Billion JPY | 3.49% |
| 2015 FY | -1.74 Billion JPY | -23.8% |
| 2015 Q2 | -305.85 Million JPY | 29.43% |
| 2015 Q4 | -548.98 Million JPY | -21.03% |
| 2015 Q3 | -453.59 Million JPY | -48.3% |
| 2015 Q1 | -433.42 Million JPY | -8.68% |
| 2014 Q2 | -322.83 Million JPY | -12.38% |
| 2014 FY | -1.4 Billion JPY | -60.28% |
| 2014 Q4 | -398.82 Million JPY | -0.18% |
| 2014 Q3 | -398.09 Million JPY | -23.31% |
| 2014 Q1 | -287.26 Million JPY | -31.45% |
| 2013 Q2 | -244.6 Million JPY | -38.36% |
| 2013 Q3 | -237.92 Million JPY | 2.73% |
| 2013 Q4 | -218.54 Million JPY | 8.14% |
| 2013 FY | -877.85 Million JPY | -23.44% |
| 2013 Q1 | -176.78 Million JPY | -5.58% |
| 2012 Q3 | -223.88 Million JPY | -53.51% |
| 2012 Q1 | -173.95 Million JPY | -27.1% |
| 2012 FY | -711.13 Million JPY | -134.24% |
| 2012 Q2 | -145.84 Million JPY | 16.16% |
| 2012 Q4 | -167.44 Million JPY | 25.21% |
| 2011 FY | -303.59 Million JPY | -190.89% |
| 2011 Q3 | -173.21 Million JPY | -272.74% |
| 2011 Q2 | -46.47 Million JPY | -187.76% |
| 2011 Q4 | -136.85 Million JPY | 20.99% |
| 2011 Q1 | 52.95 Million JPY | -16.32% |
| 2010 Q3 | 16.38 Million JPY | -85.31% |
| 2010 Q1 | 142.78 Million JPY | 12.92% |
| 2010 FY | 334.01 Million JPY | 13.7% |
| 2010 Q4 | 63.28 Million JPY | 286.26% |
| 2010 Q2 | 111.55 Million JPY | -21.87% |
| 2009 Q4 | 126.45 Million JPY | -15.21% |
| 2009 Q2 | 7.58 Million JPY | -28.43% |
| 2009 FY | 293.76 Million JPY | 0.0% |
| 2009 Q1 | 10.59 Million JPY | 0.0% |
| 2009 Q3 | 149.13 Million JPY | 1866.39% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 596.82 Million JPY | 338.924% |
| PRISM BioLab Co.,LTD | -496.86 Million JPY | -186.988% |
| GNI Group Ltd. | 13.1 Billion JPY | 110.878% |
| Linical Co., Ltd. | 725.72 Million JPY | 296.487% |
| Trans Genic Inc. | 89.43 Million JPY | 1694.383% |
| Soiken Holdings Inc. | -610 Million JPY | -133.76% |
| Cytori Cell Research Institute, Inc. | -772.74 Million JPY | -84.531% |
| AnGes, Inc. | -11.96 Billion JPY | 88.085% |
| OncoTherapy Science, Inc. | -1.12 Billion JPY | -27.226% |
| Nxera Pharma Co., Ltd. | -9.52 Billion JPY | 85.031% |
| Immuno-Biological Laboratories Co., Ltd. | 104.29 Million JPY | 1467.177% |
| NanoCarrier Co., Ltd. | -864.41 Million JPY | -64.962% |
| Carna Biosciences, Inc. | -1.11 Billion JPY | -27.662% |
| CanBas Co., Ltd. | -1.26 Billion JPY | -12.991% |
| D. Western Therapeutics Institute, Inc. | -798.55 Million JPY | -78.566% |
| RaQualia Pharma Inc. | -337.36 Million JPY | -322.673% |
| Chiome Bioscience Inc. | -1.2 Billion JPY | -18.32% |
| Kidswell Bio Corporation | -1.33 Billion JPY | -6.765% |
| PeptiDream Inc. | 6.77 Billion JPY | 121.053% |
| Oncolys BioPharma Inc. | -1.92 Billion JPY | 26.116% |
| Ribomic Inc. | -1.11 Billion JPY | -27.751% |
| SanBio Company Limited | -4.53 Billion JPY | 68.584% |
| Healios K.K. | -3.37 Billion JPY | 57.8% |
| BrightPath Biotherapeutics Co., Ltd. | -1.15 Billion JPY | -23.451% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -1.39 Billion JPY | -2.328% |
| Delta-Fly Pharma, Inc. | -1.4 Billion JPY | -1.636% |
| StemRIM | -2.07 Billion JPY | 31.313% |
| CellSource Co., Ltd. | 1.22 Billion JPY | 216.738% |
| FunPep Company Limited | -994 Million JPY | -43.456% |
| Kringle Pharma, Inc. | -888.76 Million JPY | -60.443% |
| Stella Pharma Corporation | -760.3 Million JPY | -87.551% |
| TMS Co., Ltd. | -943.25 Million JPY | -51.174% |
| Noile-Immune Biotech Inc. | -775.39 Million JPY | -83.901% |
| Cuorips Inc. | -588.48 Million JPY | -142.308% |
| K Pharma,Inc. | 366.05 Million JPY | 489.544% |
| Takara Bio Inc. | 3 Billion JPY | 147.484% |
| ReproCELL Incorporated | -409.29 Million JPY | -248.394% |
| PhoenixBio Co., Ltd. | 11.06 Million JPY | 12989.379% |
| StemCell Institute Inc. | 413.75 Million JPY | 444.633% |
| Japan Tissue Engineering Co., Ltd. | 144.5 Million JPY | 1086.77% |
| CellSeed Inc. | -697.77 Million JPY | -104.357% |